Search

everythinglearnresearchcommunity

for

Search:↓

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The study found no common cause for a girl's crystalline cataract and uncombable hair, suggesting their co-occurrence might be coincidental.

Ozone therapy might improve cancer treatment and reduce its side effects.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Taking too many vitamin and mineral supplements can cause serious health problems.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Minoxidil in breast milk may harm nursing infants.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.